Tourmaline Bio, Inc. (TRML)
NASDAQ: TRML · Real-Time Price · USD
22.96
-1.05 (-4.35%)
Nov 21, 2024, 2:13 PM EST - Market open
Tourmaline Bio Employees
Tourmaline Bio had 44 employees as of December 31, 2023.
Employees
44
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,451,750
Market Cap
588.63M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 44 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| agilon health | 1,117 |
| Definitive Healthcare | 950 |
| Exscientia | 483 |
| Ironwood Pharmaceuticals | 267 |
| Entrada Therapeutics | 159 |
| IRADIMED CORPORATION | 148 |
| EyePoint Pharmaceuticals | 121 |
| Stoke Therapeutics | 110 |
TRML News
- 7 days ago - Tourmaline Bio to Host Investor Day on Tuesday, December 10, 2024 - GlobeNewsWire
- 14 days ago - Tourmaline Bio Reports Third Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewsWire
- 21 days ago - Tourmaline Bio to Present at Upcoming Investor Conferences - GlobeNewsWire
- 5 weeks ago - Tourmaline Bio to Host Expert Webinar on Human Genetic Validation for IL-6 Inhibition in Cardiovascular Disease with Dr. Dipender Gill on Friday, November 1, 2024 - GlobeNewsWire
- 5 weeks ago - Tourmaline Bio: Looking To Go Beyond FcRn Inhibition With IL-6 Targeting - Seeking Alpha
- 5 weeks ago - Tourmaline Bio to Showcase Two Poster Presentations at the 2024 Cardiometabolic Health Congress - GlobeNewsWire
- 6 weeks ago - Tourmaline Bio Announces Formation of Cardiovascular Scientific Advisory Board - GlobeNewsWire
- 3 months ago - Tourmaline Bio Reports Second Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewsWire